Device profile of the iTind temporary implantable nitinol device for benign prostatic hyperplasia.

IF 2.7

Expert review of medical devices Pub Date : 2025-08-01 Epub Date: 2025-06-10 DOI:10.1080/17434440.2025.2517173

Levi Godard, Hersh Trivedi, Gopal Narang, Connor M Forbes

{"title":"Device profile of the iTind temporary implantable nitinol device for benign prostatic hyperplasia.","authors":"Levi Godard, Hersh Trivedi, Gopal Narang, Connor M Forbes","doi":"10.1080/17434440.2025.2517173","DOIUrl":null,"url":null,"abstract":"Introduction: Benign prostate hyperplasia (BPH) is common among men. Typical treatments include lifestyle modifications, medical management, and surgical therapy, including minimally invasive surgical therapies (MIST). iTind is a new minimally invasive option for treating BPH.Areas covered: This review is an objective assessment of the iTind device for BPH, based on published studies. The authors searched major databases for published articles that included 'iTind' and related search terms. A market overview, safety, efficacy, and durability of the device is discussed. Alternatives are compared and contrasted.Expert opinion: iTind is a safe option for the treatment of BPH in select populations, specifically those who wish to preserve ejaculatory function. It has been shown to be efficacious in treating BPH symptoms; however, available data suggest a higher rate of retreatment when compared to traditional surgery. Emerging long-term data will provide a better understanding of long-term results.","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"807-815"},"PeriodicalIF":2.7000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of medical devices","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17434440.2025.2517173","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Benign prostate hyperplasia (BPH) is common among men. Typical treatments include lifestyle modifications, medical management, and surgical therapy, including minimally invasive surgical therapies (MIST). iTind is a new minimally invasive option for treating BPH.

Areas covered: This review is an objective assessment of the iTind device for BPH, based on published studies. The authors searched major databases for published articles that included 'iTind' and related search terms. A market overview, safety, efficacy, and durability of the device is discussed. Alternatives are compared and contrasted.

Expert opinion: iTind is a safe option for the treatment of BPH in select populations, specifically those who wish to preserve ejaculatory function. It has been shown to be efficacious in treating BPH symptoms; however, available data suggest a higher rate of retreatment when compared to traditional surgery. Emerging long-term data will provide a better understanding of long-term results.

查看原文本刊更多论文

用于良性前列腺增生的iTind临时植入式镍钛诺装置的装置简介。

简介：良性前列腺增生（BPH）在男性中很常见。典型的治疗方法包括生活方式的改变、医疗管理和手术治疗，包括微创手术治疗（MIST）。它是治疗前列腺增生的一种新的微创选择。涵盖领域：本综述基于已发表的研究，对治疗前列腺增生的iTind器械进行了客观评估。作者在主要数据库中搜索了包含“iTind”和相关搜索词的已发表文章。讨论了该设备的市场概况、安全性、有效性和耐用性。选择是比较和对比的。专家意见：对于特定人群，特别是那些希望保持射精功能的人群，它是治疗前列腺增生的安全选择。它已被证明对治疗前列腺增生症状有效；然而，现有数据表明，与传统手术相比，再治疗率更高。新出现的长期数据将提供对长期结果的更好理解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert review of medical devices

自引率

0.00%

发文量